Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.

Ladabaum U, Cheng SL, Yao FY, Roberts JP.

Clin Transplant. 2011 Mar-Apr;25(2):283-91. doi: 10.1111/j.1399-0012.2010.01212.x.

PMID:
20156221
3.

Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.

Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.

Liver Transpl. 2007 Apr;13(4):543-51.

4.

Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.

Lin OS, Keeffe EB, Sanders GD, Owens DK.

Aliment Pharmacol Ther. 2004 Jun 1;19(11):1159-72.

5.

Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.

Lee KK, Kim DG, Moon IS, Lee MD, Park JH.

J Surg Oncol. 2010 Jan 1;101(1):47-53. doi: 10.1002/jso.21415.

PMID:
19798686
6.

Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model.

Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S, Farmer DG, Ghobrial RM, Yersiz H, Chen P, Schwegel K, Goldstein LI, Tong M, Busuttil RW.

Liver Transpl. 2003 Jul;9(7):672-81.

7.

Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.

Vitale A, Farinati F, Burra P, Trevisani F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Svegliati Baroni G, Virdone R, Chiaramonte M, Spolverato G, Cillo U; Italian Liver Cancer Group.

Liver Transpl. 2015 Oct;21(10):1250-8. doi: 10.1002/lt.24214.

8.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.

Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, Rotellar F, Montiel C, Alegre F, Prieto J.

Liver Transpl. 2008 Mar;14(3):272-8. doi: 10.1002/lt.21368.

9.
10.

Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.

Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, Patch D, Davidson BR, Rolles K, Burroughs AK.

Transplantation. 2006 Jun 15;81(11):1532-41.

PMID:
16770242
11.
12.

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.

Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, Rodés J, Bruix J.

Gut. 2002 Jan;50(1):123-8.

13.

Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.

Hu RH, Ho MC, Wu YM, Yu SC, Lee PH.

Clin Transplant. 2005 Apr;19(2):175-80.

PMID:
15740552
14.

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.

Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, Decaens T, Hurtova M, Memeo R, Mallat A, Duvoux C.

Ann Surg. 2009 Nov;250(5):738-46. doi: 10.1097/SLA.0b013e3181bd582b.

PMID:
19801927
15.

Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.

Marelli L, Grasso A, Pleguezuelo M, Martines H, Stigliano R, Dhillon AP, Patch D, Davidson BR, Sharma D, Rolles K, Burroughs AK.

Ann Surg Oncol. 2008 Dec;15(12):3503-11. doi: 10.1245/s10434-008-0128-3. Epub 2008 Sep 6.

PMID:
18777193
16.
18.

Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.

Vivarelli M, Cucchetti A, La Barba G, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD.

Ann Surg. 2008 Nov;248(5):857-62. doi: 10.1097/SLA.0b013e3181896278.

PMID:
18948815
19.

[Prognostic factors of hepatocellular carcinoma after liver transplantation].

Zhou LX, Yan LN.

Ai Zheng. 2006 Jun;25(6):736-9. Chinese.

PMID:
16764771
20.

Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.

Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G, Rodriguez-Davalos M, Sheiner PA.

Ann Surg Oncol. 2008 May;15(5):1383-91. doi: 10.1245/s10434-008-9851-z. Epub 2008 Mar 5.

PMID:
18320284

Supplemental Content

Support Center